TSXV - Free Realtime Quote CAD

MedMira Inc. (MIR.V)

0.0850
0.0000
(0.00%)
As of 1:44:51 PM EDT. Market Open.
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
7/31/2024
7/31/2023
7/31/2022
7/31/2021
Total Revenue
276.7340
412.5680
432.5290
952.1270
2,144.4700
Cost of Revenue
90.5940
186.0790
132.1470
648.1000
422.7280
Gross Profit
186.1400
226.4890
300.3820
304.0270
1,721.7420
Operating Expense
3,663.2520
2,656.3970
2,078.5180
1,573.5670
1,715.8460
Operating Income
-3,477.1120
-2,429.9080
-1,778.1360
-1,269.5400
5.8960
Net Non Operating Interest Income Expense
-978.5270
-896.4130
-897.5220
-562.0360
-681.6930
Pretax Income
-4,455.6390
-3,326.3210
-2,675.6580
-1,831.5760
-675.7970
Net Income Common Stockholders
-4,455.6390
-3,326.3210
-2,675.6580
-1,831.5760
-675.7970
Diluted NI Available to Com Stockholders
-4,455.6390
-3,326.3210
-2,675.6580
-1,831.5760
-675.7970
Basic EPS
-0.01
-0.01
-0.00
-0.00
-0.00
Diluted EPS
-0.01
-0.01
-0.00
-0.00
-0.00
Basic Average Shares
701,709.1660
699,888.0710
697,445.6600
697,445.6600
658,327.2990
Diluted Average Shares
701,709.1660
699,888.0710
697,445.6600
697,445.6600
658,327.2990
Total Operating Income as Reported
-3,618.0060
-2,572.9960
-1,944.3180
-1,453.2220
-184.2320
Total Expenses
3,753.8460
2,842.4760
2,210.6650
2,221.6670
2,138.5740
Net Income from Continuing & Discontinued Operation
-4,455.6390
-3,326.3210
-2,675.6580
-1,831.5760
-675.7970
Normalized Income
-4,455.6390
-3,326.3210
-2,675.6580
-1,831.5760
-675.7970
Interest Expense
964.5270
882.4130
885.5220
552.0360
653.2960
Net Interest Income
-978.5270
-896.4130
-897.5220
-562.0360
-681.6930
EBIT
-3,491.1120
-2,443.9080
-1,790.1360
-1,279.5400
-22.5010
EBITDA
-3,134.1040
-2,134.3560
-1,577.2390
-1,067.2450
185.3020
Reconciled Cost of Revenue
90.5940
186.0790
132.1470
648.1000
422.7280
Reconciled Depreciation
357.0080
309.5520
212.8970
212.2950
207.8030
Net Income from Continuing Operation Net Minority Interest
-4,455.6390
-3,326.3210
-2,675.6580
-1,831.5760
-675.7970
Normalized EBITDA
-3,134.1040
-2,134.3560
-1,577.2390
-1,067.2450
185.3020
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
7/31/2021 - 12/1/1999

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

FRX.TO Fennec Pharmaceuticals Inc.
9.04
0.00%
 
PREV.CN PreveCeutical Medical Inc.
0.0350
+16.67%
 
AGN.CN Algernon Pharmaceuticals Inc.
0.0850
0.00%
 
ARCH.V Arch Biopartners Inc.
1.7000
0.00%
 
MSCLF Satellos Bioscience Inc.
0.4820
0.00%
 
PRVCF PreveCeutical Medical Inc.
0.0248
+24.00%
 
HEM.V Hemostemix Inc.
0.0950
0.00%
 
MSCL.TO Satellos Bioscience Inc.
0.6400
-1.54%
 
APS.TO Aptose Biosciences Inc.
2.1900
-1.35%
 
NGEN.V NervGen Pharma Corp.
3.5300
-1.67%